Загрузка...
Safety of tranexamic acid in thrombotic adverse events and seizure in patients with haemorrhage: a protocol for a systematic review and meta-analysis
INTRODUCTION: Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits fibrinolysis by blocking lysine-binding sites on plasminogen, which contribute to reduced bleeding, the need for transfusion and mortality. Although there is reliable evidence of the efficacy of TXA,...
Сохранить в:
| Опубликовано в: : | BMJ Open |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7311044/ https://ncbi.nlm.nih.gov/pubmed/32571860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-036020 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|